Literature DB >> 2495120

Digoxin toxicity due to interaction of digoxin with erythromycin.

D L Maxwell1, S K Gilmour-White, M R Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495120      PMCID: PMC1835901          DOI: 10.1136/bmj.298.6673.572

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Unusually large digitalis requirements. A study of altered digoxin metabolism.

Authors:  R J Luchi; J W Gruber
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

2.  Digoxin metabolism in patients.

Authors:  U Peters; L C Falk; S M Kalman
Journal:  Arch Intern Med       Date:  1978-07

3.  Digoxin-inactivating bacteria: identification in human gut flora.

Authors:  J R Saha; V P Butler; H C Neu; J Lindenbaum
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

  3 in total
  7 in total

1.  Digoxin toxicity and erythromycin.

Authors:  A Sutton; M A Pilot
Journal:  BMJ       Date:  1989-04-22

Review 2.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 3.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 4.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 5.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

6.  Clarithromycin induced digoxin toxicity.

Authors:  S P Nordt; S R Williams; A S Manoguerra; R F Clark
Journal:  J Accid Emerg Med       Date:  1998-05

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.